Last reviewed · How we verify

NCT07485244

EEG Abnormalities in Adult ICU Patients With High Risk of Delirium

Not yet recruiting Last updated 15 April 2026
What this trial tests

trial testing Ceribell EEG System in Delirium in the Intensive Care Unit in 100 participants. Not yet recruiting.

Timeline
16 April 2026
Primary endpoint
31 December 2026
30 September 2027

Quick facts

Lead sponsorCeribell Inc.
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment100
Start date16 April 2026
Primary completion31 December 2026
Estimated completion30 September 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Ceribell Inc. — full company profile →

Who can join

18 and older, any sex, with Delirium in the Intensive Care Unit. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the prevalence of EEG abnormalities on Ceribell POC EEG in adult medical, surgical, and cardiovascular ICU patients with high risk of delirium

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Delirium in the Intensive Care Unit

Currently open trials in the same condition.

Other Ceribell Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07485244.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing